Further, the impact of SCD1 heterogeneity on metabolic risk factors, has so far only been investigated in four human studies with focus on diabetes and obesity [30], [31], metabolic syndrome (MetS) [32] or inflammation [33]. The gene discussed is SCD; the disease is metabolic syndrome.